Widespread population immunity from prior SARS-CoV-2 infections and vaccination, combined with available antivirals and diagnostics, has kept COVID-19 circulating at moderate risk levels per the WHO’s July 2026 assessment, with seasonal waves rather than exponential pandemic growth. Recent U.S. wastewater data show elevated but manageable transmission through September 2026, while global case and death counts remain far below earlier peaks, and no variant has demonstrated the combination of immune escape and virulence needed to trigger a Public Health Emergency of International Concern. Trader consensus reflects this endemic pattern and strengthened surveillance. A realistic shift could occur only if a novel, highly transmissible strain emerges with substantial severity increases or if surveillance gaps allow undetected zoonotic spillover to accelerate.